Death Benefit

Kobo eBook available

read instantly on your Kobo or tablet.

buy the ebook now

Death Benefit

by Robin Cook

Penguin Publishing Group | August 7, 2012 | Trade Paperback

Death Benefit is rated 3.5 out of 5 by 2.
Pia Grazdani is an exceptional yet aloof medical student working closely with Columbia University Medical Center’s premier scientist on cutting edge research that could revolutionize health care by creating replacement organs for critically ill patients. But when tragedy strikes in the lab, Pia, with the help of classmate George Wilson, launches an investigation into the unforeseen calamity in the hospital’s supposedly secure biosafety lab.

Meanwhile, two ex-Wall Street whiz-kids think they’ve found another loadstone in the nation’s multi-trillion dollar life insurance industry, and race to find ways to control actuarial data and securitize the policies of the aged and infirm to make another killing.

As Pia and George dig deeper into the events at the lab, one question remains unanswered: is someone attempting to manipulate private insurance information to allow investors to benefit from the deaths of others?

Format: Trade Paperback

Dimensions: 544 pages, 7.5 × 4.25 × 1.13 in

Published: August 7, 2012

Publisher: Penguin Publishing Group

Language: English

The following ISBNs are associated with this title:

ISBN - 10: 0425250369

ISBN - 13: 9780425250365

Found in: Fiction and Literature

save 9%

  • In stock online

$10.44  ea

Online Price

$10.99 List Price

or, Used from $5.04

eGift this item

Give this item in the form of an eGift Card.

+ what is this?

This item is eligible for FREE SHIPPING on orders over $25.
See details

Easy, FREE returns. See details

Item can only be shipped in Canada

Downloads instantly to your kobo or other ereading device. See details

All available formats:

Check store inventory (prices may vary)

Reviews

Rated 4 out of 5 by from good read Overall this is a very good read. I just found part 1 to be a bit slow but once i got into part 2 the book flew by, If not for part 1 I would say its a must read
Date published: 2013-02-15
Rated 3 out of 5 by from The first half of the book was fascinating but... The first half of the book was very interesting and fascinating then it went blah. I completely lost interest half way through the book so I skipped to the ending. The book was an interesting look at what conflicts biotech can cause with life insurance and Wall Street (greed, evil greed).
Date published: 2012-01-20

– More About This Product –

Death Benefit

by Robin Cook

Format: Trade Paperback

Dimensions: 544 pages, 7.5 × 4.25 × 1.13 in

Published: August 7, 2012

Publisher: Penguin Publishing Group

Language: English

The following ISBNs are associated with this title:

ISBN - 10: 0425250369

ISBN - 13: 9780425250365

From the Publisher

Pia Grazdani is an exceptional yet aloof medical student working closely with Columbia University Medical Center’s premier scientist on cutting edge research that could revolutionize health care by creating replacement organs for critically ill patients. But when tragedy strikes in the lab, Pia, with the help of classmate George Wilson, launches an investigation into the unforeseen calamity in the hospital’s supposedly secure biosafety lab.

Meanwhile, two ex-Wall Street whiz-kids think they’ve found another loadstone in the nation’s multi-trillion dollar life insurance industry, and race to find ways to control actuarial data and securitize the policies of the aged and infirm to make another killing.

As Pia and George dig deeper into the events at the lab, one question remains unanswered: is someone attempting to manipulate private insurance information to allow investors to benefit from the deaths of others?

About the Author

Dr. Robin Cook is the author of thirty previous books and is credited with popularizing the medical thriller with his wildly successful first novel, COMA. He divides his time between Florida and New Hampshire. His most recent bestsellers are CURE, INTERVENTION, and FOREIGN BODY.

Editorial Reviews

"Master of the medical thriller." — The New York Times